UK pharma major GSK reported better-than-expected second-quarter 2026 results, helped by continued growth in Specialty ...
ViiV Healthcare's two-drug HIV pill Dovato (dolutegravir/lamivudine) has matched the efficacy of Gilead's market-leading ...
US obesity specialist Ambrosia Biosciences has strengthened its clinical and scientific ranks, naming cardiometabolic drug ...
US biotech Apnimed has set the terms for its long-awaited initial public offering, seeking to raise up to $150 million as it prepares for a potential commercial launch of its lead obstructive sleep ...
The Pharmaceutical Section of the Manufacturers' Association of Israel, which represents over 201 drug companies, has sponsored the publication in English of the Guidelines for Fi ...
A commercial-stage biopharmaceutical company focused on respiratory disease and other specialty conditions. Theravance Biopharma develops and commercializes small-molecule medicines, combining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results